376270.KS · HEM파마

South Korea · RS rating 9 · As of 2026-10-14

Price29,850.00 KRW
1-day change+1.4%
RS rating (overall / 1M / 3M / 12M)9 / 9 / 7 / 70
StageBasing
Composite / Minervini / CANSLIM score40 / 15 / 63
Industry group (rank)Medical-Biomed/Biotech (95)
EPS growth Q/Q+137.1%
Sales growth Q/Q-7.4%
Distance from 52-week high+68.2%
Market cap (USD)$168.9M
Open South Korea in the interactive screener